Ed Ludwig serves as Lead Independent Director for the Board of Directors of Boston Scientific. He serves as Director of CVS, and Chairs CVS Board Finance Committee.
Additionally, Ed serves as Chairman of the Board of POCARED, Ltd., a private clinical diagnostics firm headquartered in Tel Aviv, Israel.
Ed is former Chairman of the Board, President and Chief Executive Officer of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Ed joined BD in 1979. He served as CFO from 1995 to 1999. Named President in May 1999 and Chief Executive Officer in January 2000, Ed was elected Chairman in February 2002. He served as Chief Executive Officer through September 2011 and Chairman through June 2012.
Prior to joining BD, Ed served as a senior auditor with Coopers and Lybrand (now PwC), where he earned a CPA certificate, and as a financial and strategic analyst at Kidde, Inc.
Ed served as a member of the Board of Trustees of the College of the Holy Cross from 2005 to 2013, and the Columbia Business School Board of Overseers from 2010 to 2015. He also served as a Trustee of the Hackensack University Medical Center Network Board of Trustees.
Ed is a Founding Board Member of The Center for Higher Ambition Leadership (CHL). CHL is an organization of Leaders helping Leaders build companies that achieve sustained high performance by earning the respect, trust, and commitment of their people, customers, communities, and investors.
Ed served as Director (2003-2018) and Lead Independent Director (2013-2018) of the Aetna Insurance Company. Until 2017, Ed served as Chair of the Finance, Innovation & Technology Committee of Xylem, Inc., a leading global water technology provider that launched in 2011 from the spinoff of the water-related businesses of ITT Corporation. He is a former Chairman of the Board of Directors of AdvaMed, the world’s largest medical technology association, and a past Chair of the Health Advisory Board for the Johns Hopkins Bloomberg School of Public Health.
Ed graduated from The College of the Holy Cross with a BA in Economics and Accounting and received his MBA in Finance from Columbia University.
What is Edward J. Ludwig's net worth?
The estimated net worth of Edward J. Ludwig is at least $1.75 million as of November 21st, 2024. Mr. Ludwig owns 39,398 shares of CVS Health stock worth more than $1,747,695 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Ludwig may own. Learn More about Edward J. Ludwig's net worth.
How do I contact Edward J. Ludwig?
Has Edward J. Ludwig been buying or selling shares of CVS Health?
Edward J. Ludwig has not been actively trading shares of CVS Health during the last ninety days. Most recently, on Thursday, May 2nd, Edward J. Ludwig bought 1,000 shares of CVS Health stock. The stock was acquired at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares of the company's stock, valued at $1,165,424.40. Learn More on Edward J. Ludwig's trading history.
Who are CVS Health's active insiders?
CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?
In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $53,880.00. In the last twelve months, insiders at the pharmacy operator sold shares 1 times. They sold a total of 29,473 shares worth more than $2,267,947.35. The most recent insider tranaction occured on May, 2nd when Director Edward J Ludwig bought 1,000 shares worth more than $53,880.00. Insiders at CVS Health own 0.2% of the company.
Learn More about insider trades at CVS Health. Information on this page was last updated on 5/2/2024.
